GGrantIndex
Sort

141,003 grants matching cytokine

Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC

$1,419,260
Eric A Ortlund · Emory University · U24 · FY2019 · DK

Dupilumab in the Treatment of Pediatric Alopecia Areata

$1,419,216
Emma Guttman · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · AI

Nox family NADPH oxidases: roles in innate immunity and inflammatory disease

$1,418,999
Thomas Leto · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE

$1,418,941
American College Of Radiology · U10 · FY2001 · CA

Airway inflammation and airway remodeling

$1,418,900
David H Broide · University Of California, San Diego · U19 · FY2017 · AI

Antigen Specific Therapy in CNS Autoimmune Diseases

$1,418,846
Howard L Weiner · Brigham And Women'S Hospital · P01 · FY2006 · NS

Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3

$1,418,801
Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES

Gene therapy for SCID-X1 with low dose busulfan and a SIN-lentiviral vector

$1,418,589
Sung-Yun Pai · Boston Children'S Hospital · U01 · FY2018 · AI

Late-stage development and de-risking of a novel monoclonal antibody immunotherapy for EGFR-positive solid cancers

$1,418,424
Howard M Stern · Tigatx Inc · R44 · FY2024 · CA

RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics

$1,418,421
Seungmin Hwang · Ut Southwestern Medical Center · U19 · FY2020 · AI

HUMAN MELANOMA--ETIOLOGY, PROGRESSION AND THERAPY

$1,418,371
Wistar Institute · P01 · FY2003 · CA

Sphingomab Mitigates the Multiple Pathologies of Age-Related Macular Degeneration

$1,418,276
Roger Allen Sabbadini · Lpath Therapeutics, Inc. · R44 · FY2008 · EY

Biomarkers of Atopy Beginning Early (BABE)

$1,418,167
Kirsi Jarvinen-Seppo · University Of Rochester · U19 · FY2024 · AI

Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease

$1,417,658
Scott Scarneo · Eydis Bio, Inc. · R44 · FY2025 · HL

Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection

$1,417,614
Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Human immune signatures of latent MTB infection, active disease and BCG vaccination

$1,417,299
Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2018 · AI

RAGE and Mechanisms of Vascular Dysfunction

$1,417,143
Ann Marie Schmidt · Columbia University Health Sciences · P01 · FY2008 · HL

Cardiometabolic Consequences of the Loss of Ovarian Function

$1,416,937
Kerrie Moreau · University Of Colorado Denver · U54 · FY2024 · AG

Hematopoietic stem cell (HSC) genetic and cellular therapies

$1,416,882
Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

DEVELOPMENT OF PLX-R18 CELL THERAPY AS A COUNTERMEASURE FOR HEMATOPOIETIC ACUTE RADIATION SYNDROME

$1,416,470
Chen Franco-Yehuda · Pluristem, Ltd · N01 · FY2024 · AI

Biomechanics and Inflammation in Osteoarthritis

$1,416,259
Duke University · P01 · FY2004 · AR

Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD

$1,416,252
Linda J Van Eldik · University Of Kentucky · U01 · FY2015 · AG

DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV

$1,416,167
University Of Pittsburgh At Pittsburgh · P01 · FY2000 · AI

Application of Flow Cytometry to Cell Biology

$1,415,903
Susan Sharrow · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA

Lymphocyte Dynamics

$1,415,698
William Paul · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI